Signe BioPharma Inc ®

Home

Core Values

Mission

Discovery

Business

History

Program Summary

Prevention

Products

Business Structure

Intellectual Property

Founders

Investor Information

What's New

Business Presentation

Business Plan

Plants

Bioreactors Today

Market Barriers

Markets

Capital Advantages

Conclusions

Plant Presentation

Dedication

Meet Signe

Signe Biography

Contact Us

Disclaimer

The Market Opportunity
  • Therapeutic proteins are a $24 billion market
  • Therapeutic antibodies - $8 billion market
  • Annual growth rate is 20+ %
  • Therapeutic proteins/antibodies represent 52% of the drugs in development today
  • Market share will increase with increasing availability
Source: RBC Dain Rauscher Inc

Home | Core Values | Mission | Discovery | History | Program Summary | Prevention | Products
Business Structure| Intellectual Property | Founders | Investor Information | What's New | Business Presentation
Business Plan | Bioreactors Today | Market Barriers | Markets
Capital Advantages | Conclusions | Plant Presentation | Meet Signe | Signe Biography | Contact Us | Disclaimer

© Copyright 2007 Signe BioPharma Inc. All Right Reserved.

Website powered by Network Solutions®